New hope for men with aggressive prostate cancer as experimental drug enters human trials

NCT ID NCT04221542

Recruiting now Disease control Sponsor: Amgen Source: ClinicalTrials.gov ↗

Summary

This is the first study in people testing an experimental drug called AMG 509 for advanced prostate cancer that has spread and stopped responding to standard hormone therapies. The main goals are to find a safe dose, see how the body processes the drug, and check for early signs that it might help control the cancer. The study is enrolling about 479 men whose cancer has progressed despite prior treatments.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Asan Medical Center
RECRUITING

Seoul, 138-736, South Korea
Centre Hospitalier Universitaire Vaudois
RECRUITING

Lausanne, 1011, Switzerland
Chris OBrien Lifehouse
RECRUITING

Camperdown, New South Wales, 2050, Australia
City of Hope National Medical Center
RECRUITING

Duarte, California, 91010, United States
Clinica Universidad de Navarra
RECRUITING

Pamplona, Navarre, 31008, Spain
Duke University
RECRUITING

Durham, North Carolina, 27710, United States
Emory University
RECRUITING

Atlanta, Georgia, 30322, United States
Fred Hutchinson Cancer Center
RECRUITING

Seattle, Washington, 98109, United States
Fudan University Shanghai Cancer Centre
RECRUITING

Shanghai, Shanghai Municipality, 200032, China
Hospital Clinic i Provincial de Barcelona
RECRUITING

Barcelona, Catalonia, 08036, Spain
Hospital Clinico San Carlos
RECRUITING

Madrid, 28040, Spain
Hospital Universitari Vall d Hebron
RECRUITING

Barcelona, Catalonia, 08035, Spain
Hospital Universitario 12 de Octubre
RECRUITING

Madrid, 28041, Spain
Hospital da Luz, SA
RECRUITING

Lisbon, 1500-650, Portugal
Indiana University
RECRUITING

Indianapolis, Indiana, 46202, United States
Instituto Portugues de Oncologia do Porto Francisco Gentil, EPE
RECRUITING

Porto, 4200-072, Portugal
Intermountain Medical Center
RECRUITING

Murray, Utah, 84107, United States
Istituto Oncologico della Svizzera Italiana
RECRUITING

Bellinzona, 6500, Switzerland
Kantonsspital Graubuenden
RECRUITING

Chur, 7000, Switzerland
Kantonsspital Sankt Gallen
RECRUITING

Sankt Gallen, 9007, Switzerland
Klinikum rechts der Isar der TUM
RECRUITING

München, 81675, Germany
Linkou Chang Gung Memorial Hospital of Chang Gung Medical Foundation
RECRUITING

Taoyuan District, 33305, Taiwan
Memorial Sloan Kettering Cancer Center
RECRUITING

New York, New York, 10065, United States
MidAmerica Cancer Care
RECRUITING

Merriam, Kansas, 66204, United States
Monash Medical Centre
RECRUITING

Clayton, Victoria, 3168, Australia
Nanjing Drum Tower Hospital
RECRUITING

Nanjing, 210003, China
National Cancer Center Hospital East
RECRUITING

Kashiwa-shi, Chiba, 277-8577, Japan
National Taiwan University Hospital
RECRUITING

Taipei, 10002, Taiwan
Oncology Hematology Care Incorporated
RECRUITING

Cincinnati, Ohio, 45242, United States
Peking University First Hospital
RECRUITING

Beijing, Beijing Municipality, 100034, China
Prisma Health Upstate
COMPLETED

Greenville, South Carolina, 29605, United States
Providence Saint Jude Medical Center
RECRUITING

Fullerton, California, 92835, United States
Rocky Mountain Cancer Centers
RECRUITING

Aurora, Colorado, 80012, United States
Sanford Oncology Clinic and Pharmacy
RECRUITING

Sioux Falls, South Dakota, 57104, United States
Seoul National University Hospital
RECRUITING

Seoul, 03080, South Korea
Sun Yat-sen University Cancer Center
RECRUITING

Guangzhou, Guangdong, 510060, China
The Cancer Institute Hospital of Japanese Foundation for Cancer Research
RECRUITING

Koto-ku, Tokyo, 135-8550, Japan
The First Affiliated Hospital of Nanchang University
RECRUITING

Nanchang, Jiangxi, 330006, China
Thomas Jefferson University
RECRUITING

Philadelphia, Pennsylvania, 19107, United States
Tulane Medical Center
COMPLETED

New Orleans, Louisiana, 70112, United States
US Oncology Research Investigational Products Center
RECRUITING

Irving, Texas, 75063, United States
Unidade Local de Saude de Santa Maria, EPE - Hospital de Santa Maria
RECRUITING

Lisbon, 1649-035, Portugal
United States Oncology Regulatory Affairs Corporate Office
RECRUITING

Nashville, Tennessee, 37203, United States
Universitaetsklinikum Essen
RECRUITING

Essen, 45147, Germany
Universitaetsklinikum Heidelberg
RECRUITING

Heidelberg, 69120, Germany
Universitaetsklinikum Muenster
RECRUITING

Münster, 48149, Germany
University of California San Francisco
RECRUITING

San Francisco, California, 94158, United States
University of Pittsburgh Medical Center
RECRUITING

Pittsburgh, Pennsylvania, 15232, United States
University of Texas MD Anderson Cancer Center
RECRUITING

Houston, Texas, 77030, United States
Virginia Cancer Specialists PC
RECRUITING

Fairfax, Virginia, 22031, United States
Virginia Oncology Associates
RECRUITING

Norfolk, Virginia, 23502, United States
Wake Forest University Health Sciences
RECRUITING

Winston-Salem, North Carolina, 27103, United States
Washington University
RECRUITING

St Louis, Missouri, 63110, United States
Yale New Haven Hospital
RECRUITING

New Haven, Connecticut, 06520, United States
Yokohama City University Hospital
RECRUITING

Yokohama, Kanagawa, 236-0004, Japan
Zhejiang Provincial Peoples Hospital
RECRUITING

Hangzhou, Zhejiang, 314408, China

Conditions

Explore the condition pages connected to this study.

PROSTATE CANCER